Qalsody 100 MG/15 ML vial 15ML
Ended Awarded
- Contract number
- SPE2DX25F6AFD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $10,768
Award facts
- Contract value 100% obligated
- $10,767.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $10,767.57 on September 3, 2025, for the supply of Qalsody 100 mg/15 ml vials. This firm fixed-price delivery order, with a completion date of September 24, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, which carries a total value of $499,999,999 through November 2026. The award carries no set-aside designation, allowing the vendor to compete directly in the federal pharmaceutical procurement market. The funding originates from the Defense-affiliated Medical Supply Chain, supporting the Department of Defense's healthcare and medical supply requirements.
Qalsody is a specialized pharmaceutical product used in treating specific neurological conditions and represents the type of branded prescription medication that DMS Pharmaceutical Group regularly delivers to military health facilities nationwide through its DLA contract vehicle. The company's extensive federal contract portfolio demonstrates its established role as a critical supplier in the defense pharmaceutical supply chain, consistently delivering diverse pharmaceutical products ranging from contraceptive devices to oncology treatments, vaccines, and specialty medications to support medical supply needs across Department of Defense healthcare sites worldwide.
Quick answers
Who was awarded contract SPE2DX25F6AFD?
SPE2DX25F6AFD was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 3, 2025.
How much is contract SPE2DX25F6AFD worth?
The government has obligated $10,768 on SPE2DX25F6AFD.
Is contract SPE2DX25F6AFD an order under another contract?
Yes. SPE2DX25F6AFD is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AFD competed?
The extent of competition for SPE2DX25F6AFD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award